Publications
- Phase I/II clinical trial of dendritic-cell based immunotherapy (DCVAC/PCa) combined with chemotherapy in patients with metastatic, castration-resistant prostate cancer2015 | Second Faculty of Medicine
- The Role of Cytochromes P450 and Aldo-Keto Reductases in Prognosis of Breast Carcinoma Patients2014 | First Faculty of Medicine, Second Faculty of Medicine
- Drugs for rare diseases and oncology2014 | Second Faculty of Medicine
- Importance of transcript levels of caspase-2 isoforms S and L for breast carcinoma progression2013 | First Faculty of Medicine, Second Faculty of Medicine
- Pazopanib vs. sunitinib in terms of patient preference - results of the PISCES study2012 | Second Faculty of Medicine
- Lapatinib in combination with aromatase inhibitors in the treatment of breast cancer2011 | Publication without faculty affiliation
- Trabectedin registry2011 | Publication without faculty affiliation
- NAD(P)H:quinone oxidoreductase 1 Pro187Ser polymorphism and expression do not cosegregate with clinico-pathological characteristcs of human mammary tumors2009 | First Faculty of Medicine, Second Faculty of Medicine
- Integrative analysis of mRNA and miRNA expression profiles and somatic variants in oxysterol signaling in early-stage luminal breast cancer2023 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Safety and efficacy of tafasitamab with or without lenalidomide added to first-line R-CHOP for DLBCL: the phase 1b First-MIND study2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...